GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nuvation Bio Inc (NYSE:NUVB) » Definitions » Total Tax Payable

Nuvation Bio (Nuvation Bio) Total Tax Payable : $0.00 Mil (As of Sep. 2021)


View and export this data going back to 2020. Start your Free Trial

What is Nuvation Bio Total Tax Payable?

Nuvation Bio's Total Tax Payable for the quarter that ended in Sep. 2021 was $0.00 Mil.


Nuvation Bio Total Tax Payable Historical Data

The historical data trend for Nuvation Bio's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Total Tax Payable Chart

Nuvation Bio Annual Data
Trend Dec20 Dec21
Total Tax Payable
- -

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21
Total Tax Payable Get a 7-Day Free Trial - - - - -

Nuvation Bio Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.


Nuvation Bio Total Tax Payable Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Total Tax Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio (Nuvation Bio) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
1500 Broadway, Suite 1401, New York, NY, USA, 10036
Nuvation Bio Inc is a biopharmaceutical company. The company is engaged in developing therapeutic candidates for the unmet needs in oncology. The firm operates in pharmaceutical, biotechnology and other related markets that develop small molecules and drug conjugates as treatments for cancer patients.